Neil A. Klompas, Chief Financial Officer at Zymeworks Inc. (ZYME), sold 25,000 shares at $53.25 ($1.3M) on 2020-12-09, disclosed to the SEC on 2020-12-11.
Open-market sale of $1.3M ZYME by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ZYME | SELL | 2021-03-12 | $50K | — | Filing → |
| ZYME | SELL | 2019-05-08 | $289K | — | Filing → |